Generate Biomedicines, Inc. GENB Cash Flow Statement
| Q1 '26 | ||
|---|---|---|
| -$61.71M-39.3% | ||
| $3.27M-4.1% | ||
| $6.4M+34.8% | ||
| -$80.39M-51.2% | ||
| $3.78M+403% | ||
| -$259.93M-444% | ||
| $378.89M+1,743% | ||
| $38.57M-10.1% | ||
| -$84.17M-56.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Generate Biomedicines, Inc. 's cash flow data come from?
- Every line is extracted from Generate Biomedicines, Inc. 's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.